Medications Category Archives — Page 2 of 73 — DC Medical Malpractice & Patient Safety Blog Published by Washington, D.C. Personal Injury Lawyers

October 18, 2022

U.S. fixes ACA ‘family glitch’ as insurers start key open enrollment season

The Biden Administration has tackled the “family glitch” in Obamacare, issuing new eligibility rules that will open up more affordable health insurance for many more poor, working poor, and middle-class Americans who otherwise might struggle to pay for coverage, even as provided by their employers.

This change in health care regulation is taking effect, even as tens of millions of people roll into an important period to protect their well-being — the annual “open enrollment” months for health coverage under the Affordable Care Act, by many employers, as well as for those eligible for Medicare.

The Treasury Department’s new regulations on the “family glitch” affects as many as 5 million people, more than half of them children, according to the nonpartisan, independent Commonwealth Fund. Here is how the Associated Press described what federal regulators are doing to make health coverage more affordable to many more people under the Affordable Care Act or Obamacare:

October 14, 2022

U.S. toughens law to ensure patients’ full access to their medical records

by Patrick A. Malone

Patients have hit a red-letter day in the long, too-difficult struggle to win control of a crucial part of their care — their electronic medical care records. Hospitals and other caregiving institutions no longer can block access to these documents, with federal law now holding them accountable for any runarounds they may try.

As Stat, a medical and science news site, reported:

“Under federal rules taking effect [Oct. 6,2022], health care organizations must give patients unfettered access to their full health records in digital format. No more long delays. No more fax machines. No more exorbitant charges for printed pages. Just the data, please — now. ‘My great hope is that this will turn the tide on the culture of information blocking,’ said Lisa Bari, CEO of Civitas Networks for Health, a nonprofit that supports medical data sharing. ‘It’s a ground level thing to me: We need to make sure information flows the way patients want it to.’”

October 12, 2022

A newly diagnosed apnea patient finds healthy sleep costly and treatment aids questionable

by Patrick A. Malone

With millions of patients struggling with long delays in getting replacements for night-breathing devices recalled by their manufacturer over the machines’ potential health risks, a seasoned health journalist has reported an intriguing, personal counterpoint on the growing prevalence of the problem of sleep apnea and its routine, costly, inconvenient care.

Jay Hancock, who has been a senior correspondent for the independent, nonpartisan Kaiser Health News service (KHN) for a decade and has reported on health care, business, finance, and the U.S. State Department for the Baltimore Sun and the Virginian Pilot, penned his piece in admitted self-interest. That’s because he suffered bouts of drowsiness during the day and his wife told him he snored.

He decided to undergo exams to see if he had sleep disorders. Tests gave him a diagnosis of moderate apnea. Because of his journalistic background, he wrote that he decided he needed to learn more, reporting:

October 5, 2022

Medicare premium fix fails to deal with deeper problems at FDA

by Patrick A. Malone

Seniors had reason to let out a whimper of pleasure when the Biden Administration announced that Medicare’s monthly, part B premiums would go down by 3% next year — the first such decline in a decade.

To be sure, the sums that they will save will be small, with most of those covered on the government insurance program next year paying $164.90 a month for Part B and seeing a savings of $5.20. But over the course of 2023, administration officials say, this sum will help seniors recoup what they were charged in 2022 when they were hit one of the largest, single-year Medicare premium increases in recent times.

So, while the head-spinning fiscal mess of Medicare costs may be straightening out a tad, the underlying debacle that caused it all is still festering and ready to cause more prescription drug regulatory fiascoes.

September 28, 2022

Hollywood puts appearances above all in fad injections of diabetes drug

by Patrick A. Malone

Troubling but perhaps predictable news is traveling from a vanity trend-setting capital of this country: Hollywood stars have made the taking of a relatively new prescription drug, targeted for the treatment of diabetes, into a fad.

The injectable drug semaglutide, whose brand name is Ozempic, has become a must-have among A-listers because of one of its important outcomes among most users: dramatic weight loss. As Variety, one of the entertainment industry’s leading trade-media sources, reported about Ozempic:

“The drug is an insulin regulator for the pre-diabetic, made by the Danish pharma juggernaut Novo Nordisk, whose primary side effect is dramatic weight loss. It has saturated the industry in recent months, helping the beautiful and wealthy shed extra pounds in the never-ending Los Angeles pastime of optimizing appearances. Hollywood nutritionist Matt Mahowald tells Variety that the chief benefits of the injections are ‘moderating and pulling back insulin secretion and slowing down your stomach from emptying. It promotes satiation from food.’

September 25, 2022

Appellate judges zero in on corporate twists of bankruptcy shield

by Patrick A. Malone

Federal appeals judges have expressed skepticism about the scheming by Big Pharma and other big corporations to twist U.S. bankruptcy laws to let wealthy, powerful defendants shield themselves from major claims of harms filed by plaintiffs seeking justice in civil courts.

The U.S. Court of Appeals for the Third Circuit in Philadelphia has been asked to rule on the “Texas two-step” that Johnson & Johnson resorted to when hit with an avalanche of lawsuits over its legendary baby powder and claims by tens of thousands of patients who assert that asbestos-tainted talc contributed to or caused their cancer, NPR reported, noting:

“An attorney for Johnson and Johnson faced probing questions … over the corporation’s use of a controversial bankruptcy maneuver that has frozen tens of thousands of lawsuits linked to Johnson’s baby powder. During the hearing, members of a three-judge panel of the United States Court of Appeals for the Third Circuit in Philadelphia asked whether J&J had used the legal strategy to gain ‘a litigation advantage’ over roughly 40,000 cancer patients who have sued the company.”

September 21, 2022

It’s past time for Congress to reconsider propriety of FDA ‘user fees’

by Patrick A. Malone

Members of Congress, as usual, are racing to meet a deadline: This time, to determine the funding for the federal Food and Drug Administration, an agency with some of the most consequential responsibilities affecting Americans’ health.

In their furious political and financial machinations, though, lawmakers aren’t asking the tough, critical question about the FDA’s leading revenue source:

Is it a good idea for Big Pharma and medical device makers to pay most of the cost to run the nation’s watchdog of these giant, wealthy industries?

September 11, 2022

U.S. judge cites religious freedoms in striking down insurance coverage for HIV drugs

by Patrick A. Malone

While increasing numbers of Americans tell pollsters that they are forgoing religion and seeing its practice diminish in importance in their lives, those with religious fervor are finding a federal judiciary willing to delve into the complexity of faith and medicine in deeply polarizing ways.

The looming midterm elections, pollsters say, already have been upended by the U.S. Supreme Court’s overturning of a half-century of settled law in turning back to the states critical decisions about women’s reproductive health and the allowance of abortions, including in cases involving rape and incest.

A federal judge in Texas with demonstrated extreme views has further stoked the increasing fires over religion and health care by ruling unconstitutional the process by which Obamacare decides what kinds of preventive health care must be covered by private health insurance, as the New York Times and other media outlets have reported.

September 9, 2022

White House conference, first in 50 years, will focus on diet and nutrition

by Patrick A. Malone

The Biden Administration this month will tackle one of the major, persistent challenges that perplexes and damages the health and well-being of most regular folks: what they eat, as well as their regular sources of food.

The scheduled Sept. 28 White House Conference on Hunger, Nutrition, and Health will be only the second of its kind in modern history and the first in almost a half a century, NPR has reported, adding that it will be a timely and notable event. As Dariush Mozaffarian, a cardiologist and dean of the Friedman School of Nutrition Science and Policy at Tufts University, told the broadcast news reporters:

“We’re really in a nutrition crisis in this country.”

September 6, 2022

Medicine struggles with hype, disinformation, and miscommunication

by Patrick A. Malone

The quality of medical-scientific information is strained — and patients should know this, be warned, and watch for ways to protect themselves from bungled communication, bluster, hype, misinformation, and disinformation.

Although regular folks may have unprecedented access via the internet to resources on medical services and developments, a trio of recent news articles underscore the importance of the familiar warning Caveat emptor (buyer beware):

California has found a narrow path between doctors’ free speech rights and reining in clinicians spreading false information about coronavirus vaccinations and treatments, the New York Times reported, adding that legislators granted new powers granted to regulators to deal with what became a significant problem during the pandemic.